↓ Skip to main content

Dove Medical Press

Potential of Pembrolizumab in Metastatic or Recurrent Head and Neck Cancer: Evidence to Date

Overview of attention for article published in OncoTargets and therapy, April 2020
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
59 Mendeley
Title
Potential of Pembrolizumab in Metastatic or Recurrent Head and Neck Cancer: Evidence to Date
Published in
OncoTargets and therapy, April 2020
DOI 10.2147/ott.s196252
Pubmed ID
Authors

Michael G McCusker, Dennis Orkoulas-Razis, Ranee Mehra

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 59 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 17%
Researcher 6 10%
Student > Doctoral Student 6 10%
Student > Ph. D. Student 6 10%
Student > Bachelor 4 7%
Other 14 24%
Unknown 13 22%
Readers by discipline Count As %
Medicine and Dentistry 20 34%
Biochemistry, Genetics and Molecular Biology 10 17%
Nursing and Health Professions 3 5%
Immunology and Microbiology 3 5%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Other 5 8%
Unknown 16 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 February 2022.
All research outputs
#7,360,834
of 25,387,668 outputs
Outputs from OncoTargets and therapy
#377
of 3,016 outputs
Outputs of similar age
#143,479
of 396,814 outputs
Outputs of similar age from OncoTargets and therapy
#12
of 85 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 3,016 research outputs from this source. They receive a mean Attention Score of 2.9. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 396,814 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 85 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.